Corporate News

INMUNOTEK HELLAS new subsidiary

November 2020

INMUNOTEK HELLAS is established in Athens, Greece, as a new European subsidiary of INMUNOTEK. With INMUNOTEK HELLAS, there are currently five subsidiaries of the INMUNOTEK Group around the world, and the second in Europe.
More info

INMUNOTEK Top-10 according to Pharma Tech Outlook

October 2020

INMUNOTEK featured among the top-10 European immunotherapy providers by Pharma Tech Outlook, a specialized magazine in Pharma and Life Science technologies. The immunotherapy field covers different immune-based treatments for an increasing number of diseases. from allergies or cancer to autoimmune or infectious diseases.
More info

INMUNOTEK at the A TU SALUD awards

September 2020

INMUNOTEK is awarded for its research and innovative work in the field of Immunology in the IX Edition of the A TU SALUD Awards of the La Razón newspaper. The event was attended by the Mayor of Madrid, Mr. José Luis Martínez Almeida, who delivered the awards, and the Minister of Health of the Community of Madrid, Mr. Enrique Ruiz Escudero
More info

INMUNOTEK receives the National Innovation Award

Premio Nacional de Innovación_InmunotekJuly 2020

Their Majesties the Kings of Spain present INMUNOTEK with the National Innovation Award in the Small and Medium-Sized Entities (SME) category. The act presided over by the Kings took place at the Valencia Science Museum. It was attended by the Minister of Science and Innovation, Pedro Duque, local authorities. jury and guests. The National Innovation Award is the highest award given by the Government of Spain to recognize those entities that make innovation their main business growth strategy.
More info

INMUNOTEK innovative entity granted by BLOCKPCT

APTEJune 2020

INMUNOTEK obtains the certificate as innovative entity in the private and independent blockchain network of the Spanish Science and Technology Parks (BLOCKPCT) promoted by the Association of Science and Technology Parks of Spain (APTE).
More info